List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #861 to #910.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. ANGLIB 003-001Abrupt closure case 1
  2. ANGLIB 003-002Abrupt closure case 2
  3. ANGLIB 003-003Abrupt closure case 3
  4. ANGLIB 003-004Abrupt closure case 4
  5. ANGLIB 003-005Abrupt closure case 5
  6. ANGPT1Angiopoietin 1
  7. ANH1Porphyria
  8. ANKLAggressive NK-cell leukemia
  9. ANOVAAnalysis of variance
  10. ANPAtrial natriuretic peptide
  11. ANTHEM–TIMI-32Anticoagulation With Rnapc2 To Eliminate Mace/Timi 32
  12. ANTIBIOAntibiotic Therapy After An Acute Myocardial Infarction
  13. ANTIPSYCHOTIC DRUGAntipsychotics
  14. ANTIPSYCHOTIC DRUGSAtypical antipsychotics
  15. ANUGTrench mouth
  16. ANZ-CarvedilolAustralia-New Zealand Heart Failure Research Collaborative Group Carvedilol Trial
  17. AOAorta
  18. AOMOtitis media
  19. AOSLoeys-Dietz syndrome
  20. AOSDAdult-onset Still's disease
  21. APAlkaline phosphatase
  22. AP-1 siteAP-1 Binding Site
  23. APAFAblation For Paroxysmal Atrial Fibrillation (Apaf) Trial
  24. APAPParacetamol detailed information
  25. APASSAntiphospholipid Antibody Stroke Study
  26. APBPremature atrial contraction
  27. APCEDSAutoimmune polyendocrine syndrome
  28. APC Resistance, Leiden TypeFactor V Leiden
  29. APC geneAPC (gene)
  30. APC resistanceActivated protein C resistance
  31. APC resistance, Leiden typeFactor V Leiden
  32. APDAvoidant personality disorder
  33. APECEDAutoimmune polyendocrine syndrome
  34. APECED syndromeAutoimmune polyendocrine syndrome
  35. APEX AMIAssessment Of Pexelizumab In Acute Myocardial Infarction
  36. APHAntepartum haemorrhage
  37. API Healthcare Coloufree Childrens ParacetamolParacetamol detailed information
  38. API Healthcare Colourfree Childrens Paracetamol Double StrengthParacetamol detailed information
  39. API Healthcare ParacetamolParacetamol detailed information
  40. APLAcute promyelocytic leukemia
  41. APLAUSEAnti-Platelet Treatment After Intravascular Ultrasound Guided Optimal Stent Expansion
  42. APL differentiation syndromeRetinoic acid syndrome
  43. APMLAcute promyelocytic leukemia
  44. APML differentiation syndromeRetinoic acid syndrome
  45. APO-AtenolAtenolol
  46. APO-GoApomorphine
  47. APO-Go PenApomorphine
  48. APOCARDImaging In Cardiac Transplant Patients
  49. APPIAmyloid precursor protein
  50. APPRAISE-1Safety Of The Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial

View ( | ) (20 | 50 | 100 | 250 | 500)